HCPCS Level II › C codes › C9301

C9301

Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

TerminatedHCPCS Level II code.

Still listed by CMS but carries a termination date, so it is not valid for a current date of service.

Terminated with effect from 2025-06-30. First published 2025. CMS still lists this code in the current quarterly file - it carries a termination date rather than being removed.

What has happened to this code

Every change the publisher made, from 2025 to now.

  1. April 2025 Added to the code set Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
  2. July 2025 Terminated by CMS